Update of FDA's Critical Path Initiative.
Khleif
Samir
S
Cancer Vaccine Section, National Cancer Institute, Bethesda, MD 20892, USA.
D014408:Biomarkers, Tumor; D035843:Biomedical Research / Q000458:organization & administration*; D002986:Clinical Trials as Topic; D004345:Drug Industry / Q000458:organization & administration*; D006801:Humans; D010601:Pharmacology, Clinical / Q000458:organization & administration*; D014481:United States; D014486:United States Food and Drug Administration
D014408:Biomarkers, Tumor